![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
About us
GenoGla Diagnostics was created as a spin-off of the University of Algarve, Faro, Portugal.
GenoGla was first created to serve as a platform to commercially explore the newly developed products and technologies that are included in an international patent application (PCT/PT2009000046; U. S. Patent 61/136.315 filled in 27 August 2008) as well as to pursue research and explore new findings and patents originating from collaboration research contracts (e.g. on bone and cardiovascular health, skin care, cancer and diagnostics).
Team
Dina SimesPhD Chief Executive Officer (CEO) & Co-Managing Director
Carla São Bento ViegasPhD Chief Operating Officer (COO) & Co-Managing Director
PhD in Biochemistry – Molecular and Cellular Biology, University of Algarve. Carla is a senior researcher at CCMAR (Centre of Marine Sciences, University of Algarve), working within the Functional Biochemistry and Proteomics group. She co-founded GenoGla Diagnostics in May 2009 and currently serves as Chief Operating Officer and co-managing director. Her expertise bridges academic research and biotechnology innovation, with a focus on molecular diagnostics, protein biochemistry, and translational applications in human health.
Aim
|
![]() |
|
|
Copyright © 2025GenoGla - Research and diagnosticsgenogla@genogla.com |